Furthermore, cisplatin resistance is associated with cancer stem cells (CSCs), in which ALDH1A1, as a novel CSCs marker, Its enhanced activity has been found identified across a number of cisplatin-resistant NSCLC cell lines and tumor samples (MacDonagh et al., 2018). Here, ALDH1A1 is linked to cancer.